Shprecher David R, Adler Charles H, Zhang Nan, Shill Holly A, Belden Christine M, Driver-Dunckley Erika, Mehta Shyamal H, Davis Kathryn J, Sue Lucia I, Zamrini Edward, Beach Thomas G
Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ, United States.
Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ, United States.
Clin Neurol Neurosurg. 2020 May;192:105728. doi: 10.1016/j.clineuro.2020.105728. Epub 2020 Feb 6.
Subjective excessive daytime sleepiness, commonly measured with the Epworth Sleepiness Scale (ESS), is associated with cognitive impairment in Parkinson disease (PD). Significant correlation between subject and informant responses has been reported in neurologically healthy individuals. We sought to assess this correlation in patients with PD.
854 individuals in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) had subject as well as informant-completed ESS completed within one year of a movement disorder exam and cognitive assessment. Correlations were evaluated using Spearman's rank correlation coefficients.
Overall, 397/854(46.5 %) were female with mean age of 77.5 (SD 8.3). 572 (67 %) were cognitively normal (CogNL), 135 (15.8 %) had mild cognitive impairment (MCI) and 147 (17.2 %) dementia. Spearman R correlations (all with p < 0.001) between subject and informant ESS responses were 0.73 overall, 0.67 for the CogNL group, 0.79 for the MCI group, 0.79 for those with dementia. Of 175 with clinically probable PD, 115 (65.7 %) were CogNL, 38 had MCI, and 22 (12.6 %) dementia. For subjects with PD correlations (all with p < 0.001) were 0.65 for PD-CogNL, 0.83 for PD-MCI, and 0.70 for those with PD-dementia.
These significant correlations between subject and informant-completed ESS can be useful in guiding clinical trials designed to assess efficacy of potential treatments for excessive daytime sleepiness for the general population and for patients with PD, even those having cognitive impairment.
主观日间过度嗜睡通常用爱泼沃斯思睡量表(ESS)来衡量,它与帕金森病(PD)的认知障碍有关。在神经功能正常的个体中,已报道受试者与知情者的回答之间存在显著相关性。我们试图评估PD患者中的这种相关性。
在亚利桑那州衰老与神经退行性疾病研究(AZSAND)中,854名个体在运动障碍检查和认知评估的一年内完成了受试者以及知情者填写的ESS。使用斯皮尔曼等级相关系数评估相关性。
总体而言,397/854(46.5%)为女性,平均年龄77.5岁(标准差8.3)。572人(67%)认知正常(CogNL),135人(15.8%)有轻度认知障碍(MCI),147人(17.2%)患有痴呆症。受试者与知情者ESS回答之间的斯皮尔曼R相关性(均p<0.001)总体为0.73,CogNL组为0.67,MCI组为0.79,痴呆症患者为0.79。在175名临床可能为PD的患者中,115人(65.7%)认知正常,38人有MCI,22人(12.6%)患有痴呆症。对于PD患者,PD-CogNL的相关性为0.65(均p<0.001),PD-MCI为0.83,PD痴呆症患者为0.70。
受试者与知情者填写的ESS之间存在的这些显著相关性,可有助于指导旨在评估针对一般人群和PD患者(即使是有认知障碍的患者)日间过度嗜睡潜在治疗效果的临床试验。